Simplesa Expands ‘Deanna Protocol’ Diet Supplement Choices for ALS Patients
Simplesa, a nutrition company established in 2013 after the amyotrophic lateral sclerosis (ALS) community showed its support for…
Articles by Margarida Azevedo, MSc
Baylor and UCB Partner to Develop Therapies for ALS, Other Neurodegenerative Ills
Baylor College of Medicine and the Belgium-based biopharmaceutical company UCBÂ announced that they have entered into a strategic partnership,…
Biogen Promotes New Industry Fund for ALS Research with $5M Matching Gift
The Target ALS Foundation, a collaborative research consortium, received a $5 million matching-gift donation from Biogen to help establish the foundation’s new Industry…
ALS Association Honors 4 for Outstanding Contributions at ‘Heroes Luncheon’
The ALS Association (ALSA)Â recently held its sixth annual Heroes Luncheon, honoring outstanding people with amyotrophic lateral sclerosis (ALS)…
ALS Association Awards Almost $756K to 5 Projects Aiming to Improve Clinical Care
The ALS Association announced that it has awarded a total of $755,855 in financial grants supporting new clinical management projects to address…
ProMIS Forms Key Advisory Boards to Advance Its ALS, Alzheimer’s Therapies
ProMIS Neurosciences announced that it has established Business (BAB) and Scientific (SAB) advisory boards to advance the company’s work. ProMIS is developing its…
ALS Progression in Mice Appears to Stop With Novel Treatment to Spinal Cord
Oregon State University researchers were able to stop the progression of amyotrophic lateral sclerosis (ALS, or Lou Gehrig’s disease)…
Environmental Toxin a Possible Cause of Symptoms of ALS, Alzheimer’s Disease
Researchers at the Institute for EthnoMedicine and the University of Miami Brain Endowment Bank have discovered that chronic exposure to an…
Potential ALS Treatments May Be Identified by New Discoveries About Certain Proteins
University of Kyoto researchers discovered that a protein associated with a gene involved in cancer suppression, the VHL protein, and…
Amylyx Appoints Nobel Laureate Walter Gilbert to Board of Directors
Amylyx Pharmaceuticals, a company developing a innovative therapeutic for amyotrophic lateral sclerosis (ALS, or Lou Gehrig’s disease), recently announced…